The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) was established in 1993. Inaugurated in Lisbon in 1995, it is one of the EU’s decentralised agencies. The EMCDDA exists to provide the EU and its Member States with a factual overview of European drug problems and a solid evidence base to support the drugs debate. Today it offers policymakers the data they need for drawing up informed drug laws and strategies. It also helps professionals and practitioners working in the field pinpoint best practice and new areas of research.
The EMCDDA was set up to provide 'factual, objective, reliable and comparable information concerning drugs, drug addiction and their consequences'
Objective: To raise awareness on, and interest in, the role of the European Prevention Curriculum (EUPC) in advocating for the application of science-based strategies in policy- and decision-making at local level.
This webinar is part of the series of webinars that the EMCDDA has been organising over the past year around the theme of COVID-19. The purpose of the webinars is to help those working in the drugs field understand how drug users, and those supporting them, are coping with the pandemic and to share knowledge and experience.
Objective: To explore innovative programmes providing solutions in the field of homelessness and drugs.
